Scott Minick

Scott Minick is an experienced executive and board member with a diverse background in healthcare and biotechnology. Currently serving as a Board Member at BPGbio, Inc. and an Advisor at Alzheon, Inc., Scott has also held significant roles at organizations such as Beth Israel Deaconess Medical Center and Sierra Nevada College, where contributions as Board Member and Trustee have been noteworthy. Previously, Scott served as a Venture Partner and Managing Director at ARCH Venture Partners, Executive Chairman at Aira, and held positions as a CEO at BIND Therapeutics and member of the Board of Directors at both Chiasma and Alzheon, Inc. Scott Minick earned an MBA from Kellogg Graduate School of Management at Northwestern University and has attended UC San Diego.